Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Minimal correlation between physical exercise capacity and daily activity in patients with intermittent claudication.

Gommans LN, Hageman D, Jansen I, de Gee R, van Lummel RC, Verhofstad N, Scheltinga MR, Teijink JA.

J Vasc Surg. 2016 Apr;63(4):983-9. doi: 10.1016/j.jvs.2015.10.060. Epub 2016 Jan 21.

2.

Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication: A Randomized Clinical Trial.

Fakhry F, Spronk S, van der Laan L, Wever JJ, Teijink JA, Hoffmann WH, Smits TM, van Brussel JP, Stultiens GN, Derom A, den Hoed PT, Ho GH, van Dijk LC, Verhofstad N, Orsini M, van Petersen A, Woltman K, Hulst I, van Sambeek MR, Rizopoulos D, Rouwet EV, Hunink MG.

JAMA. 2015 Nov 10;314(18):1936-44. doi: 10.1001/jama.2015.14851.

PMID:
26547465
3.

The effect of supervised exercise therapy on physical activity and ambulatory activities in patients with intermittent claudication.

Fokkenrood HJ, Lauret GJ, Verhofstad N, Bendermacher BL, Scheltinga MR, Teijink JA.

Eur J Vasc Endovasc Surg. 2015 Feb;49(2):184-91. doi: 10.1016/j.ejvs.2014.11.002. Epub 2014 Dec 12.

4.

Physical activity monitoring in patients with peripheral arterial disease: validation of an activity monitor.

Fokkenrood HJ, Verhofstad N, van den Houten MM, Lauret GJ, Wittens C, Scheltinga MR, Teijink JA.

Eur J Vasc Endovasc Surg. 2014 Aug;48(2):194-200. doi: 10.1016/j.ejvs.2014.04.003. Epub 2014 May 28.

5.

Paternal lifestyle as a potential source of germline mutations transmitted to offspring.

Linschooten JO, Verhofstad N, Gutzkow K, Olsen AK, Yauk C, Oligschläger Y, Brunborg G, van Schooten FJ, Godschalk RW.

FASEB J. 2013 Jul;27(7):2873-9. doi: 10.1096/fj.13-227694. Epub 2013 Mar 28.

6.

Evaluation of benzo(a)pyrene-induced gene mutations in male germ cells.

Verhofstad N, van Oostrom CT, Zwart E, Maas LM, van Benthem J, van Schooten FJ, van Steeg H, Godschalk RW.

Toxicol Sci. 2011 Jan;119(1):218-23. doi: 10.1093/toxsci/kfq325. Epub 2010 Oct 20.

PMID:
20961952
7.

Benzo(a)pyrene induces similar gene expression changes in testis of DNA repair proficient and deficient mice.

Verhofstad N, Pennings JL, van Oostrom CT, van Benthem J, van Schooten FJ, van Steeg H, Godschalk RW.

BMC Genomics. 2010 May 26;11:333. doi: 10.1186/1471-2164-11-333.

8.

DNA adduct kinetics in reproductive tissues of DNA repair proficient and deficient male mice after oral exposure to benzo(a)pyrene.

Verhofstad N, van Oostrom CT, van Benthem J, van Schooten FJ, van Steeg H, Godschalk RW.

Environ Mol Mutagen. 2010 Mar;51(2):123-9. doi: 10.1002/em.20516.

9.

New methods for assessing male germ line mutations in humans and genetic risks in their offspring.

Verhofstad N, Linschooten JO, van Benthem J, Dubrova YE, van Steeg H, van Schooten FJ, Godschalk RW.

Mutagenesis. 2008 Jul;23(4):241-7. doi: 10.1093/mutage/gen022. Epub 2008 May 20. Review.

PMID:
18495641
10.

Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy.

Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S, Verhofstad N, Nakabeppu Y, Baum LG, Bakkers J, Mayo KH, Poirier F, Griffioen AW.

Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15975-80. Epub 2006 Oct 16.

Supplemental Content

Loading ...
Support Center